Loading clinical trials...
Loading clinical trials...
Active aGeing And Personalised Service's Ecosystem
AGAPE aims to implement an advanced technology platform that provides services to older adults, formal and informal caregivers, and caregiving organizations.
AGAPE aims to promote an active and healthy lifestyle in the over-65 population and, in parallel, to improve the quality of life of caregivers (by reducing the burden of care), while also overcoming the possible digital literacy gap of users. The advantage of the AGAPE platform is to offer users highly personalized services based on their needs and digital capabilities, and innovative technologies integrated with each other that fit within the spatial services already available in local ecosystems. The project involves an impact-by-design approach that engages older people, caregivers, and managers of care organizations in a co-creation strategy. In addition, the solutions offered by the AGAPE platform will be extensively tested in a preliminary pre-validation phase in order to effectively meet the needs of end users.
Age
65 - No limit years
Sex
ALL
Healthy Volunteers
No
IRCCS Fondazione Don Carlo Gnocchi, Firenze
Florence, Italy
Start Date
February 6, 2024
Primary Completion Date
November 13, 2024
Completion Date
March 31, 2025
Last Updated
March 13, 2025
68
ACTUAL participants
Active aGeing And Personalised service's Ecosystem (AGAPE)
DEVICE
Lead Sponsor
Fondazione Don Carlo Gnocchi Onlus
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions